Breaking News, Collaborations & Alliances

Celltrion, Nan Fung Group Set Up Bio CDMO in China

Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Celltrion and Nan Fung Group together have established Vcell Healthcare Limited, a joint venture (JV) company between both parties.   At the formation of the JV, Vcell Healthcare has simultaneously signed a licensing agreement with Celltrion. Vcell will obtain the exclusive rights in mainland China to develop, manufacture and commercialize three US. .FDA and EMA approved biosimilar products from Celltrion: CT-P13 (Remsima), CT-P10 (Truxima) and CT-P6 (Herzuma). Remsima, referencing Remicade (Inf...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters